Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PBYI
#2959
Puma Biotechnology Inc - Common Stock
9.0
6
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.95%
Monthly Change
+16.30%
6 month change
+64.43%
Year Change
+79.41%
Previous Close
9.2
4
Open
9.0
6
Low
9.0
6
High
9.0
6
Volume
59
Markets
US Stock Market
Healthcare
Biotechnology
PBYI
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
40.26 M
41.33 M
46.64 M
48.21 M
49.61 M
50.88 M
51.62 M
Valuation ratios
Enterprise value
426.07 M
159.61 M
214.73 M
233.21 M
149.14 M
273.08 M
438.37 M
Price to earnings ratio
—
—
—
10.06
4.92
9.75
17.69
Price to sales ratio
—
—
0.81
0.91
0.65
1.32
2.04
Price to cash flow ratio
—
—
-11.72
7.97
3.85
7.21
11.37
Price to book ratio
—
—
8.59
4.03
1.63
2.31
0.92
Enterprise value to EBITDA ratio
-20.1
12.68
6.41
5.3
3.63
5.76
9.2
Profitability ratios
Return on assets %
-0.25
-0.13
0
0.09
0.14
0.14
0.04
Return on equity %
10.08
11.91
0
0.4
0.33
0.24
0.06
Return on invested capital %
-115.32
4.41
0.4
104.46
76.32
162.59
49.67
Gross margin %
100
74.84
75.84
73.4
72.06
74.53
77.92
Operating margin %
-13.51
0.51
10.4
13.85
13.44
16.33
13.42
EBITDA margin %
-9.42
4.97
14.7
18.69
17.82
20.76
17.67
Net margin %
-26.65
-11.51
0
9.16
13.14
13.62
14.49
Liquidity ratios
Quick ratio
1.25
1.21
1.67
1.5
1.45
1.93
2.64
Current ratio
1.28
1.28
1.73
1.57
1.54
2
2.91
Inventory turnover
—
12.06
9.47
10.8
8.15
10.55
1.13
Asset turnover
0.94
1.08
1.02
1.04
1.04
1.06
0.29
Solvency ratios
Debt to assets ratio
0.34
0.43
0.44
0.28
0.1
0
0
Debt to equity ratio
-14.12
-39.69
4.55
1.23
0.24
0
0
Long term debt to total assets ratio
0.34
0.45
0.46
0.44
0.32
0.1
0.53
Long term debt to total equity ratio
-14.12
-41.7
4.72
1.91
0.74
0.17
0.74
Per share metrics
Operating cash flow per share
—
—
-0.35
0.57
0.79
0.83
0.81
EBIT per share
—
—
0.53
0.69
0.63
0.74
0.59
EBITDA per share
—
—
0.75
0.93
0.84
0.94
0.93
Total debt per share
—
—
2.19
2.1
1.37
0
0
Cash per share
—
—
1.04
1.03
1.77
1.81
1.65
Net current asset value per share
—
—
2.99
3.28
3.01
3.21
2.76
Tangible book value per share
—
—
-1.09
-0.16
0.83
1.76
1.94
Working capital per share
—
—
1.26
1.19
1.05
1.61
1.81
Book value per share
—
—
0.48
1.12
1.88
2.57
2.63
News
Is Puma Biotechnology (PBYI) a Great Value Stock Right Now?
PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised
Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates
Earnings Preview: Puma Biotech (PBYI) Q2 Earnings Expected to Decline
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why
PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised
Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript
Puma Biotechnology, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-05-08
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?